These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

96 related articles for article (PubMed ID: 206399)

  • 1. Lymphoblastoid cell lines from sarcoid patients.
    Horsmanheimo M; Virolainen M; Nikoskelainen J; Fudenberg HH
    Clin Immunol Immunopathol; 1978 Apr; 9(4):419-24. PubMed ID: 206399
    [No Abstract]   [Full Text] [Related]  

  • 2. Studies on antibody surveillance to EB virus-induced antigen in patients with sarcoidosis and nasopharyngeal carcinoma by indirect immunofluorescence.
    Naito M; Akiyama Y; Kato S; Tachibana T; Sakai T
    Biken J; 1973 Dec; 16(4):141-8. PubMed ID: 4363326
    [No Abstract]   [Full Text] [Related]  

  • 3. A seroepidemiological study of Epstein-Barr virus and other viral antigens in sarcoidosis.
    Byrne EB; Evans AS; Fouts DW; Israel HL
    Am J Epidemiol; 1973 May; 97(5):355-63. PubMed ID: 4349694
    [No Abstract]   [Full Text] [Related]  

  • 4. Antibodies to Epstein-Barr virus and some other herpesviruses in patients with sarcoidosis, pulmonary tuberculosis and erythema nodosum.
    Nikoskelainen J; Hannuksela M; Palva T
    Scand J Infect Dis; 1974; 6(3):209-16. PubMed ID: 4370734
    [No Abstract]   [Full Text] [Related]  

  • 5. [Epstein-Barr virus-specific antibody pattern in sarcoid uveitis with and without systemic manifestations].
    Tanaka H; Sunakawa M; Arai I; Zhang YJ; Okinami S
    Nippon Ganka Gakkai Zasshi; 1986 Dec; 90(12):1663-8. PubMed ID: 3030080
    [No Abstract]   [Full Text] [Related]  

  • 6. [Epstein-Barr-virus-antibodies and lymphocytotoxic serum-antibodies in patients with sarcoidosis].
    Becker FW; Gallmeier WM; Hertenstein C; Kalden JR
    Klin Wochenschr; 1972 Oct; 50(19):927-8. PubMed ID: 4343096
    [No Abstract]   [Full Text] [Related]  

  • 7. [Epstein-Barr-virus antibodies in sarcoidosis (author's transl)].
    Gergely L; Czeglédy J; Mándi I
    Klin Wochenschr; 1973 Sep; 51(17):884-5. PubMed ID: 4355663
    [No Abstract]   [Full Text] [Related]  

  • 8. Invited discussion: relationship of titers of Epstein-Barr virus to cell-mediated immunity in patients with Hodgkin's disease.
    Levine PH; Reisher JI
    Natl Cancer Inst Monogr; 1973 May; 36():85-7. PubMed ID: 4355354
    [No Abstract]   [Full Text] [Related]  

  • 9. Antibody to Epstein-Barr virus and cellular immunity in Hodgkin's disease and chronic lymphatic leukemia.
    Hesse J; Andersen E; Levine PH; Ebbesen P; Halberg P; Reisher JI
    Int J Cancer; 1973 Jan; 11(1):237-43. PubMed ID: 4364323
    [No Abstract]   [Full Text] [Related]  

  • 10. Antibodies in human sera to soluble and viral antigens found in Burkitt lymphoma and other lymphoblastoid cell lines.
    Vonka V; Benyesh-Melnick M; McCombs RM
    J Natl Cancer Inst; 1970 Apr; 44(4):865-72. PubMed ID: 11515054
    [No Abstract]   [Full Text] [Related]  

  • 11. In vitro cellular immunity to Epstein-Barr virus in normal human subjects.
    Fimmel PJ; Lai PK; Keast D; Alpers MP; Mackay-Scollay EM
    Int J Cancer; 1974 May; 13(5):599-605. PubMed ID: 4367339
    [No Abstract]   [Full Text] [Related]  

  • 12. Cellular immunity: immune responses and the herpes-like virus.
    Glade PR; Hirschhorn K
    Cell Immunol; 1970 Oct; 1(4):359-61. PubMed ID: 4331868
    [No Abstract]   [Full Text] [Related]  

  • 13. Humoral and cellular immunity to EBV and lymphoid cell line antigens in human lymphoma.
    Levine PH; Connelly RR; Herberman RB; McCoy JL; Fabrizio PL
    IARC Sci Publ (1971); 1975; (11 Pt 2):225-35. PubMed ID: 191366
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antibodies to various herpesviruses in sera from patients with sarcoidosis.
    Wahren B; Carlens E; Espmark A; Lundbeck H; Löfgren S; Madar E; Henle G; Henle W
    J Natl Cancer Inst; 1971 Oct; 47(4):747-55. PubMed ID: 4328945
    [No Abstract]   [Full Text] [Related]  

  • 15. Evaluation of delayed hypersensitivity reactions to lymphoid cell lines and antibodies to Epstein-Barr virus.
    Levine PH; Ho JH; Nkrumah F; Andrese AP
    IARC Sci Publ (1971); 1978; (24 Pt 2):893-8. PubMed ID: 221411
    [No Abstract]   [Full Text] [Related]  

  • 16. [Immunologic changes in patients with Hodgkin's disease in clinical remission and recurrence].
    Ares BR; Sasiain MD; Brezavscek DM; Fejes M; Bachmann AE
    Medicina (B Aires); 1981; 41(3):287-92. PubMed ID: 6275237
    [No Abstract]   [Full Text] [Related]  

  • 17. Persistence of virulent canine distemper virus in lymphoblastoid cell lines.
    Friedlander JM; Summers BA; Appel MJ
    Arch Virol; 1985; 86(1-2):47-62. PubMed ID: 2994601
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The Guillain-Barré syndrome.
    MacGregor GA
    Lancet; 1972 Dec; 2(7788):1197. PubMed ID: 4117616
    [No Abstract]   [Full Text] [Related]  

  • 19. Neutralizing antibodies to Epstein-Barr virus in healthy populations and patients with infectious mononucleosis.
    Hewetson JF; Rocchi G; Henle W; Henle G
    J Infect Dis; 1973 Sep; 128(3):283-9. PubMed ID: 4353929
    [No Abstract]   [Full Text] [Related]  

  • 20. Herpes simplex-RAJI(A44), a new cell line for serologic testing by immunofluorescence.
    Seigneurin JM; Desgranges C; Lavoue MF; de-The G
    J Immunol; 1976 Sep; 117(3):950-2. PubMed ID: 182883
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.